Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

IV.a

Bronchospasm - Wheezing - Asthma

Publications

Gouel-Chéron A, Neukirch C, Aubier B, Montravers P, Nicaise P, Chollet-Martin S, Mertes PM, Aubier M, Longrois D

Anaphylactic bronchospasm during general anesthesia is not related to asthma.

Allergy. 2015;70(4):453-6

Bishop MJ, O'Donnell JT, Salemi JR

Mivacurium and bronchospasm.

Anesthesia and analgesia. 2003;97(2):484-485

Rajchert DM, Pasquariello CA, Watcha MF, Schreiner MS

Rapacuronium and the risk of bronchospasm in pediatric patients.

Anesthesia and analgesia. 2002;94(3):488-93; table of contents

Kron SS

Severe bronchospasm and desaturation in a child associated with rapacuronium.

Anesthesiology. 2001;94(5):923-4